🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Harrow, Inc.

HROW Healthcare
$39.4 +$1.76 (4.68%)
Market Cap: $1.47 B
Gurus Holding
5
Popularity Rank
#1660
% of Shares Held
4.61%
Net Activity (Q1 2026)
-$26.32 M

Guru Ownership Trend

Guru Analysis for Harrow, Inc. (HROW)

Harrow, Inc. (HROW), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $67.73 M.

Top institutional holders include Private Capital and Renaissance Technologies (RenTech).

Notably, Private Capital has expressed high conviction in this stock, allocating 5.48% of their equity portfolio to it.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $26.32 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Chuck Royce reduced exposure by 92.2%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q1 2026)

+$924,482
Total Buy Value
New Buys 1
Additions 0
-$27.24 M
Total Sell Value
Reductions 4
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
4
Net Buyers
1

FAQs for Harrow, Inc. (HROW)

Major holders include Private Capital ($55.08 M), Renaissance Technologies (RenTech) ($2.98 M), Chuck Royce ($1.4 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.72 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $26.32 M, with 1 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited HROW. The total reported sell value was $27.24 M.

Yes, 1 managers opened new positions in HROW, and 0 increased their existing holdings. The total reported buy value was $924,482.

Portfolio Manager % Portfolio Activity Shares Value Report Date
5.48% Reduce -15.3% 1,562,000 $55.08 M Q1 2026
0.00% Reduce -19.4% 84,579 $2.98 M Q1 2026
0.01% Reduce -92.2% 39,713 $1.4 M Q1 2026
0.00% New Buy 26,219 $924,482 Q1 2026
0.00% Reduce -14.9% 6,548 $230,882 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form